Skip to main content
. 2017 Aug 24;8(44):77540–77551. doi: 10.18632/oncotarget.20560

Figure 6. The combination of TERT gene copy number gains and MYC overexpression was associated with the shortest DFS and OS in cohort #1.

Figure 6

Lower MYC levels annulled the negative effect of TERT gains on DFS and OS (A, B). In cases without TERT gains, MYC levels had no effect on patient survival (C, D).